Liquid Oxygen Devices

Global Liquid Oxygen Devices Market to Reach US$13.8 Billion by 2030

The global market for Liquid Oxygen Devices estimated at US$11.4 Billion in the year 2024, is expected to reach US$13.8 Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Hospitals, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$8.6 Billion by the end of the analysis period. Growth in the Outpatient Facilities segment is estimated at 2.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.1 Billion While China is Forecast to Grow at 6.3% CAGR

The Liquid Oxygen Devices market in the U.S. is estimated at US$3.1 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.8 Billion by the year 2030 trailing a CAGR of 6.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 2.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.

Global Liquid Oxygen Devices Market – Key Trends & Drivers Summarized

Why Are Liquid Oxygen Devices Gaining Importance in Healthcare?

Liquid oxygen devices have become an essential component in modern healthcare, supporting patients with respiratory conditions and critical medical needs. Unlike traditional compressed gas oxygen cylinders, liquid oxygen devices offer greater portability, efficiency, and long-term oxygen storage. These systems are widely used for home-based oxygen therapy, hospitals, and emergency medical services, providing a reliable source of medical-grade oxygen. The increasing prevalence of chronic obstructive pulmonary disease (COPD), asthma, and other respiratory illnesses has significantly boosted demand for liquid oxygen devices. With a growing aging population and the rising incidence of pulmonary diseases, healthcare systems are integrating liquid oxygen solutions to enhance patient care and mobility. Additionally, liquid oxygen devices ensure a higher purity level and a continuous oxygen supply compared to conventional methods, making them ideal for critical care patients. The shift toward home healthcare solutions has further accelerated market growth, as patients seek convenient, lightweight, and easy-to-use oxygen delivery systems. With advancements in medical technology and oxygen therapy solutions, liquid oxygen devices continue to play a vital role in improving patient outcomes and enhancing quality of life.

What Are the Latest Technological Advancements in Liquid Oxygen Devices?

Technological advancements have significantly improved the design, functionality, and efficiency of liquid oxygen devices. One of the most notable developments is the integration of compact, lightweight systems that provide extended oxygen supply without frequent refills. Portable liquid oxygen concentrators have revolutionized home oxygen therapy, enabling patients to maintain an active lifestyle without being tethered to bulky equipment. Additionally, smart monitoring systems are being incorporated into liquid oxygen devices, allowing real-time tracking of oxygen levels, device performance, and patient usage patterns. These innovations help healthcare providers monitor patients remotely, ensuring timely intervention and improved adherence to oxygen therapy. Another key advancement is the development of high-efficiency cryogenic storage tanks that minimize oxygen evaporation and enhance longevity. Sustainable and eco-friendly designs are also emerging, with manufacturers focusing on recyclable materials and energy-efficient liquid oxygen systems. Moreover, technological integration with wearable devices and mobile applications is streamlining oxygen therapy, offering patients personalized insights and automated alerts. As the demand for user-friendly and intelligent oxygen delivery solutions increases, manufacturers are investing in research and development to enhance safety, reliability, and accessibility in liquid oxygen devices.

How Is Consumer Demand Shaping the Liquid Oxygen Devices Market?

The increasing awareness of respiratory health, coupled with the rising burden of chronic lung diseases, has significantly influenced consumer demand for liquid oxygen devices. Patients and caregivers are actively seeking compact, lightweight, and user-friendly solutions that enable greater mobility and independence. The trend toward home-based oxygen therapy has led to a surge in demand for portable and refillable liquid oxygen units, as they offer prolonged oxygen supply and convenience compared to traditional cylinder-based systems. Additionally, the preference for non-invasive respiratory support is driving innovation in liquid oxygen technology, with manufacturers focusing on silent, efficient, and customizable delivery systems. The COVID-19 pandemic has further heightened awareness of oxygen therapy, leading to increased investments in medical oxygen infrastructure and production. The expansion of telehealth and remote patient monitoring has also contributed to market growth, as healthcare providers emphasize real-time oxygen tracking and patient management. Furthermore, affordability and insurance coverage for oxygen therapy equipment play a crucial role in purchasing decisions, with many patients opting for cost-effective, long-term liquid oxygen solutions. As consumer expectations evolve, companies are prioritizing ease of use, portability, and smart connectivity in liquid oxygen devices, ensuring optimal patient experience and compliance with prescribed therapy.

What Are the Primary Growth Drivers of the Liquid Oxygen Devices Market?

The growth in the liquid oxygen devices market is driven by several factors, including advancements in oxygen therapy technology, the increasing prevalence of respiratory disorders, and the rising demand for home healthcare solutions. One of the key growth drivers is the surge in chronic lung disease cases, particularly COPD and asthma, which require long-term oxygen therapy. The aging global population is another critical factor, as elderly individuals are more susceptible to respiratory conditions and rely on efficient oxygen delivery systems. Additionally, the increasing adoption of portable liquid oxygen devices has expanded market opportunities, allowing patients to maintain mobility and independence. The healthcare industry`s shift toward telemedicine and remote monitoring has further fueled demand for liquid oxygen devices, as real-time tracking enhances patient management and adherence to treatment plans. The pandemic-induced oxygen shortages have also prompted governments and healthcare providers to invest in robust oxygen infrastructure, boosting the production and distribution of liquid oxygen systems. Moreover, technological advancements in cryogenic storage and automated oxygen delivery mechanisms have improved device efficiency, minimizing oxygen waste and enhancing patient comfort. Regulatory support and favorable reimbursement policies for oxygen therapy equipment continue to influence market dynamics, making liquid oxygen devices more accessible to a broader patient base. As the emphasis on respiratory health grows, the liquid oxygen devices market is poised for sustained expansion, catering to the evolving healthcare landscape and improving patient outcomes worldwide.

SCOPE OF STUDY:

The report analyzes the Liquid Oxygen Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
End-Use (Hospitals, Outpatient Facilities, Home Care)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• Air Liquide Healthcare
• Air Products and Chemicals, Inc.
• AmcareMed
• Brise Chemicals
• CAIRE Inc.
• Chart Industries
• Cryofab Inc.
• DEHAS Medical Systems
• DFC Tank Pressure Vessel Manufacturer
• Essex Industries
• Krison Engineering Works
• Linde Engineering
• MATHESON
• Maverick Oxygen
• Messer Group
• Neometrix Group
• Praxair (a Linde company)
• ProResp Inc.
• Stirling Cryogenics
• Weclearmed

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.